Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
The built-in innate immunity in the human body combats various diseases and their causative agents. One of the components of this system is Toll-like receptors (TLRs), which recognize structurally conserved molecules derived from microbes and/or endogenous molecules. Nonetheless, under certain condi...
Main Authors: | Nasir Javaid, Farzana Yasmeen, Sangdun Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/9/441 |
Similar Items
-
Identification and characterization of toll-like receptor (TLR) 2 and 4 mutations in colorectal
by: Davoodi, Homa
Published: (2009) -
Toll-like Receptors from the Perspective of Cancer Treatment
by: Nasir Javaid, et al.
Published: (2020-01-01) -
Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
by: Mariya Farooq, et al.
Published: (2021-10-01) -
Toll-Like Receptors
by: Aycan Kundakcı, et al.
Published: (2012-08-01) -
Toll-like Receptor-Dependent Negative Effects of Opioids: A Battle between Analgesia and Hyperalgesia
by: Masaud Shah, et al.
Published: (2017-05-01)